Clinical Trials in Mississippi (MS) | Mississippi Clinical Drug Trials & Studies

You are viewing Clinical Trials In Mississippi

Have multiple conditions? Click here

Showing 1-100 of 356

There are 356 trials in Mississippi

Name	City	State	Zip
The Effects of Tactile Speech Feedback on Stuttering Frequency	University	MS	38677
Efficacy of Behavioral Insomnia Treatment for Chronic Migraine	University	MS	38677
Study of the Safety and Efficacy of TH-302 in Combination With Gemcitabine Compared With Gemcitabine Alone in Previously Untreated Patients With Pancreatic Adenocarcinoma	Tupelo	MS	38801
Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-Resistant Prostate Cancer	Tupelo	MS	38801
Ph II of a Novel Anti-angiogenic Agent in Combination With Chemotherapy for the Treatment of Non-Small Cell Lung Cancer	Tupelo	MS	38801
Efficacy and Safety of Metoclopramide Nasal Spray Solution in Diabetic Patients With Gastroparesis	Tupelo	MS	38801
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)	Tupelo	MS	38801
The Dual Antiplatelet Therapy Study (DAPT Study)	Tupelo	MS	38801
Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPI	Tupelo	MS	38801
Efficacy and Safety Study of Leukocyte Interleukin,Injection (LI) to Treat Cancer of the Oral Cavity	Tupelo	MS	38801
TAXUS LibertÄ“ Post Approval Study	Tupelo	MS	38801
Effect of Otamixaban Versus Unfractionated Heparin + Eptifibatide in Patients With Unstable Angina/Non ST Elevation Myocardial Infarction Undergoing Early Invasive Strategy	Tupelo	MS	38801
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2 Overexpressing Metastatic Breast Cancer Patients	Tupelo	MS
VISTA-16 Trial: Evaluation of Safety and Efficacy of Short-term A-002 Treatment in Subjects With Acute Coronary Syndrome	Tupelo	MS	38801
Effects of Dronedarone on Atrial Fibrillation Burden in Subjects With Permanent Pacemakers	Tupelo	MS	38801
A Study of the Effects of Actemra on Vaccination in Patients With Rheumatoid Arthritis on Background Methotrexate (VISARA)	Tupelo	MS	33801
A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis	Tupelo	MS	33801
Comparison of the SUperaÂ® PERipheral System in the Superficial Femoral Artery	Tupelo	MS	38801
Longitudinal Surveillance Registry (LSR) of ACUITY Spiral	Tupelo	MS	38801
Rheos HOPE4HF Trial	Tupelo	MS	38801
Evaluation of the WATCHMAN LAA Closure Device in Patients With Atrial Fibrillation Versus Long Term Warfarin Therapy	Tupelo	MS	38801
Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX02-0018	Southaven	MS	38671
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)	Rolling Fork	MS	39159
Efficacy and Safety Study to Evaluate Combination Therapy With Nebivolol and Lisinopril vs. Placebo and Monotherapy in Patients With Stage 2 Diastolic Hypertension	Rolling Fork	MS	39159
Welchol as Monotherapy for Type 2 Diabetes Mellitus	Port Gibson	MS	39150
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus	Port Gibson	MS	39150
A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)	Picayune	MS	39466
Treatment for Aggression and Agitation in Patients With Alzheimer's Disease	Picayune	MS	39466
A Study in Schizophrenia Patients	Picayune	MS	39466
Continued Safety Monitoring of Solanezumab in Alzheimer's Disease	Picayune	MS	39466
A Long-Term, Open-Label, Study on Schizophrenia	Picayune	MS	39466
A Study of the Effect of LY2189265 on Blood Pressure and Heart Rate in Type 2 Diabetes	Picayune	MS	39466
Prasugrel Versus Placebo in Adult Sickle Cell Disease	Picayune	MS	39466
A Study in Patients With Rheumatoid Arthritis on Background Methotrexate Therapy	Picayune	MS	39466
A Rheumatoid Arthritis Study in Patients on a Background Treatment of Methotrexate	Picayune	MS	39466
A Rheumatoid Arthritis Study in Patients	Picayune	MS	39466
A Study in Patients With Rheumatoid Arthritis	Picayune	MS	39466
A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome	Picayune	MS	39466
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy	Picayune	MS	39466
Toxicity and Safety Evaluation of an Omega-3 Fatty Acid and a Multivitamin and Antioxidant Nutritional Preparation	Pearl	MS	39208
Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer	Pascagoula	MS	39581
Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallopian Tube Cancer	Pascagoula	MS	39581
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer	Pascagoula	MS	39581
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery	Pascagoula	MS	39581
Treatment Decision Making Based on Blood Levels of Tumor Cells in Women With Metastatic Breast Cancer Receiving Chemotherapy	Pascagoula	MS	39581
Erlotinib and Bevacizumab in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer	Pascagoula	MS	39581
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy	Pascagoula	MS	39581
Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer	Pascagoula	MS	39581
Gemcitabine and Cisplatin in Treating Patients With Stage I Non-Small Cell Lung Cancer That Was Removed by Surgery	Pascagoula	MS	39581
Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer	Pascagoula	MS	39581
Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer	Pascagoula	MS	39581
Topotecan With or Without Aflibercept in Treating Patients With Extensive-Stage Small Cell Lung Cancer	Pascagoula	MS	39581
Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia	Pascagoula	MS	39581
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer	Pascagoula	MS	39581
Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases	Pascagoula	MS	39581
Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma	Pascagoula	MS	39581
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer	Pascagoula	MS	39581
Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer	Pascagoula	MS	39581
Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer	Pascagoula	MS	39581
Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer	Pascagoula	MS	39581
Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic Cancers	Pascagoula	MS	39581
ABT-888 and Temozolomide in Treating Patients With Recurrent Glioblastoma	Pascagoula	MS	39581
Patient, Physician, and Nurse Factors Associated With Entry Onto Clinical Trials and Finishing Treatment in Patients With Primary or Recurrent Uterine, Endometrial, or Cervical Cancer	Pascagoula	MS	39581
Radiation Therapy With or Without Chemotherapy in Patients With Stage I or Stage II Cervical Cancer Who Previously Underwent Surgery	Pascagoula	MS	39581
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery	Pascagoula	MS	39581
Efficacy and Safety of Zoledronic Acid ( Every 4 Weeks vs. Every 12 Weeks) in Patients With Documented Bone Metastases From Bone Cancer	Pascagoula	MS	39581
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy	Pascagoula	MS
A Study to Assess the Safety and Effect of TC-5214 in Patients With Major Depressive Disorder.	Pascagoula	MS
Study of Denosumab as Adjuvant Treatment for Women With High Risk Early Breast Cancer Receiving Neoadjuvant or Adjuvant Therapy (D-CARE)	Pascagoula	MS
A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder	Pascagoula	MS
Compare the Efficacy of Cinacalcet vs Traditional Vitamin D for Secondary Hyperparathyroidism (SHPT) Among Subjects Undergoing Hemodialysis	Pascagoula	MS
Biomarkers of Anti-TNF-Î± Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients	Pascagoula	MS
Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin	Pascagoula	MS
Evaluation of Efficacy and Safety of Fostamatinib Monotherapy Compared With Adalimumab Monotherapy in Patients With Rheumatoid Arthritis (RA)	Pascagoula	MS
Linagliptin Versus Placebo in Type 2 Diabetic Patients With Inadequate Glycaemic Control on Metformin in Combination With Pioglitazone	Olive Branch	MS
Comparison of Tiotropium in the HandhiHaler Versus the Respimat in Chronic Obstructive Pulmonary Disease	Olive Branch	MS
Effects of Rivastigmine Patch on Activities of Daily Living and Cognition in Patients With Severe Dementia of the Alzheimer's Type	Ocean Springs	MS	39564
Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease	Ocean Springs	MS	39564
Efficacy and Safety of BGG492 as Adjunctive Treatment in Patients With Partial Onset Seizures	Ocean Springs	MS	39564
An Observational Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants	Newton	MS	39345
Efficacy and Safety of Methylphenidate HCl ER Capsules in Children and Adolescents With ADHD	Madison	MS	39110
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer	Kessler AFB	MS	39534
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery	Kessler AFB	MS	39534
Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer	Kessler AFB	MS	39534
Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia	Kessler AFB	MS	39534
Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement	Kessler AFB	MS	39534
SPICE Trialâ€”ASsessment of the Effect of Lifestyle Intervention Plus Water-soluble cInnamon extraCt in Delaying the Onset of Diabetes Trial.	Kessler AFB	MS	39534
Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma	Kessler AFB	MS	39534
Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer	Kessler AFB	MS	39534
Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic Cancers	Kessler AFB	MS	39534
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery	Kessler AFB	MS	39534
Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma	Jackson	MS	39216
ErbB2 Over-Expressing Metastatic Breast Cancer Study Using Paclitaxel, Trastuzumab, and Lapatinib	Jackson	MS	39202
EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer	Jackson	MS	39202
Oral HYCAMTIN Plus Whole Brain Radiation Therapy In Treatment Of Brain Metastases Resulting From Non-Small Lung Cancer	Jackson	MS	39202
Retapamulin Versus Linezolid in the Treatment of SITL and Impetigo Due to MRSA	Jackson	MS	39202
Ofatumumab Versus Rituximab Salvage Chemoimmunotherapy Followed by Autologous Stem Cell Transplant in Relapsed or Refractory Diffuse Large B Cell Lymphoma	Jackson	MS	39202
Single Agent Ofatumumab Vs. Single Agent Rituximab in Follicular Lymphoma Relapsed After Rituximab-Containing Therapy	Jackson	MS	39202
Efficacy and Safety of Zoledronic Acid ( Every 4 Weeks vs. Every 12 Weeks) in Patients With Documented Bone Metastases From Bone Cancer	Jackson	MS	39202
Treatment Based on Molecular Profiling Diagnosis Carcinoma of Unknown Primary Site	Jackson	MS	39202

View Clinical Trial Facilities in Mississippi

Showing 1-100 of 356